These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33046894)

  • 1. A systematic evaluation of the design and context dependencies of massively parallel reporter assays.
    Klein JC; Agarwal V; Inoue F; Keith A; Martin B; Kircher M; Ahituv N; Shendure J
    Nat Methods; 2020 Nov; 17(11):1083-1091. PubMed ID: 33046894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering regulatory DNA sequences and noncoding genetic variants using neural network models of massively parallel reporter assays.
    Movva R; Greenside P; Marinov GK; Nair S; Shrikumar A; Kundaje A
    PLoS One; 2019; 14(6):e0218073. PubMed ID: 31206543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding enhancers using massively parallel reporter assays.
    Inoue F; Ahituv N
    Genomics; 2015 Sep; 106(3):159-164. PubMed ID: 26072433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MPRAnalyze: statistical framework for massively parallel reporter assays.
    Ashuach T; Fischer DS; Kreimer A; Ahituv N; Theis FJ; Yosef N
    Genome Biol; 2019 Sep; 20(1):183. PubMed ID: 31477158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of massively parallel reporter assays enables prediction of regulatory function across cell types.
    Kreimer A; Yan Z; Ahituv N; Yosef N
    Hum Mutat; 2019 Sep; 40(9):1299-1313. PubMed ID: 31131957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome-integrated massively parallel reporter assay reveals DNA sequence determinants of cis-regulatory activity in neural cells.
    Maricque BB; Dougherty JD; Cohen BA
    Nucleic Acids Res; 2017 Feb; 45(4):e16. PubMed ID: 28204611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding how cis-regulatory function is encoded in DNA sequence using massively parallel reporter assays and designed sequences.
    White MA
    Genomics; 2015 Sep; 106(3):165-170. PubMed ID: 26072432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay.
    Melnikov A; Murugan A; Zhang X; Tesileanu T; Wang L; Rogov P; Feizi S; Gnirke A; Callan CG; Kinney JB; Kellis M; Lander ES; Mikkelsen TS
    Nat Biotechnol; 2012 Feb; 30(3):271-7. PubMed ID: 22371084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-scale high-resolution mapping of activating and repressive nucleotides in regulatory regions.
    Ernst J; Melnikov A; Zhang X; Wang L; Rogov P; Mikkelsen TS; Kellis M
    Nat Biotechnol; 2016 Nov; 34(11):1180-1190. PubMed ID: 27701403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence-based correction of barcode bias in massively parallel reporter assays.
    Lee D; Kapoor A; Lee C; Mudgett M; Beer MA; Chakravarti A
    Genome Res; 2021 Sep; 31(9):1638-1645. PubMed ID: 34285053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus on your locus with a massively parallel reporter assay.
    McAfee JC; Bell JL; Krupa O; Matoba N; Stein JL; Won H
    J Neurodev Disord; 2022 Sep; 14(1):50. PubMed ID: 36085003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of enhancer activity in early human neurodevelopment using Massively Parallel Reporter Assay (MPRA) and forebrain organoids.
    Capauto D; Wang Y; Wu F; Norton S; Mariani J; Inoue F; Crawford GE; Ahituv N; Abyzov A; Vaccarino FM
    Sci Rep; 2024 Feb; 14(1):3936. PubMed ID: 38365907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical considerations for the analysis of massively parallel reporter assays data.
    Qiao D; Zigler CM; Cho MH; Silverman EK; Zhou X; Castaldi PJ; Laird NH
    Genet Epidemiol; 2020 Oct; 44(7):785-794. PubMed ID: 32681690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay.
    Kheradpour P; Ernst J; Melnikov A; Rogov P; Wang L; Zhang X; Alston J; Mikkelsen TS; Kellis M
    Genome Res; 2013 May; 23(5):800-11. PubMed ID: 23512712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity.
    Inoue F; Kircher M; Martin B; Cooper GM; Witten DM; McManus MT; Ahituv N; Shendure J
    Genome Res; 2017 Jan; 27(1):38-52. PubMed ID: 27831498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QuASAR-MPRA: accurate allele-specific analysis for massively parallel reporter assays.
    Kalita CA; Moyerbrailean GA; Brown C; Wen X; Luca F; Pique-Regi R
    Bioinformatics; 2018 Mar; 34(5):787-794. PubMed ID: 29028988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining TSS-MPRA and sensitive TSS profile dissimilarity scoring to study the sequence determinants of transcription initiation.
    Guzman C; Duttke S; Zhu Y; De Arruda Saldanha C; Downes NL; Benner C; Heinz S
    Nucleic Acids Res; 2023 Aug; 51(15):e80. PubMed ID: 37403796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massively parallel reporter assays in cultured mammalian cells.
    Melnikov A; Zhang X; Rogov P; Wang L; Mikkelsen TS
    J Vis Exp; 2014 Aug; (90):. PubMed ID: 25177895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STARR-seq - principles and applications.
    Muerdter F; Boryń ŁM; Arnold CD
    Genomics; 2015 Sep; 106(3):145-150. PubMed ID: 26072434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lentiMPRA and MPRAflow for high-throughput functional characterization of gene regulatory elements.
    Gordon MG; Inoue F; Martin B; Schubach M; Agarwal V; Whalen S; Feng S; Zhao J; Ashuach T; Ziffra R; Kreimer A; Georgakopoulos-Soares I; Yosef N; Ye CJ; Pollard KS; Shendure J; Kircher M; Ahituv N
    Nat Protoc; 2020 Aug; 15(8):2387-2412. PubMed ID: 32641802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.